C. R. Kinsolving

1.5k total citations · 1 hit paper
30 papers, 1.2k citations indexed

About

C. R. Kinsolving is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, C. R. Kinsolving has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in C. R. Kinsolving's work include Synthesis and biological activity (9 papers), Synthesis and Biological Evaluation (9 papers) and Synthesis and Reactions of Organic Compounds (8 papers). C. R. Kinsolving is often cited by papers focused on Synthesis and biological activity (9 papers), Synthesis and Biological Evaluation (9 papers) and Synthesis and Reactions of Organic Compounds (8 papers). C. R. Kinsolving collaborates with scholars based in United States and Hungary. C. R. Kinsolving's co-authors include Robert L. Post, Craig D. Albright, David L. Beaver, Vassil St. Georgiev, Stanley D. Allen, G. B. MULLEN, Jeffrey T. Mitchell, J. G. Michael, S Goldstein and Robert A. Mack and has published in prestigious journals such as Journal of Biological Chemistry, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

C. R. Kinsolving

21 papers receiving 1.1k citations

Hit Papers

Membrane Adenosine Triphosphatase as a Participant in the... 1960 2026 1982 2004 1960 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. R. Kinsolving United States 9 721 259 180 121 120 30 1.2k
Per J. Wistrand Sweden 26 1.4k 1.9× 252 1.0× 211 1.2× 63 0.5× 82 0.7× 75 2.1k
Sen T. Kau United States 15 627 0.9× 184 0.7× 68 0.4× 85 0.7× 94 0.8× 46 1.4k
Johan Järnefelt Finland 19 888 1.2× 168 0.6× 217 1.2× 55 0.5× 73 0.6× 36 1.3k
Keith Elliott United Kingdom 20 642 0.9× 182 0.7× 140 0.8× 30 0.2× 158 1.3× 55 1.1k
Theodor Bücher Germany 20 1.3k 1.8× 370 1.4× 71 0.4× 84 0.7× 126 1.1× 44 2.0k
F. Irreverre United States 22 947 1.3× 172 0.7× 192 1.1× 138 1.1× 124 1.0× 44 2.2k
Richard J. Guillory United States 22 943 1.3× 171 0.7× 69 0.4× 88 0.7× 58 0.5× 50 1.3k
Eugene E. Quist United States 15 382 0.5× 239 0.9× 54 0.3× 59 0.5× 105 0.9× 32 745
John S. Cook United States 29 1.2k 1.6× 209 0.8× 90 0.5× 99 0.8× 165 1.4× 66 2.0k
N Ogino Japan 29 688 1.0× 242 0.9× 152 0.8× 25 0.2× 72 0.6× 118 3.1k

Countries citing papers authored by C. R. Kinsolving

Since Specialization
Citations

This map shows the geographic impact of C. R. Kinsolving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. R. Kinsolving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. R. Kinsolving more than expected).

Fields of papers citing papers by C. R. Kinsolving

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. R. Kinsolving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. R. Kinsolving. The network helps show where C. R. Kinsolving may publish in the future.

Co-authorship network of co-authors of C. R. Kinsolving

This figure shows the co-authorship network connecting the top 25 collaborators of C. R. Kinsolving. A scholar is included among the top collaborators of C. R. Kinsolving based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. R. Kinsolving. C. R. Kinsolving is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Warren, R P, R. W. Sidwell, John H. Huffman, et al.. (1990). Effect of oxamisole on immune parameters of mice infected with murine hepatitis. International Journal of Immunopharmacology. 12(6). 625–630. 3 indexed citations
3.
Palmer, Gene C., James C. Strand, Lesley A. Radov, et al.. (1989). Selection of orally active antifungal agents from 3,5-substituted isoxazolidine derivatives based on acute efficacy-safety profiles. Antimicrobial Agents and Chemotherapy. 33(6). 895–905. 11 indexed citations
4.
Kinsolving, C. R., et al.. (1989). Flavodilol. Journal of Cardiovascular Pharmacology. 14(1). 127–141. 6 indexed citations
5.
Blosser, James C., et al.. (1989). Flavodilol. Journal of Cardiovascular Pharmacology. 14(1). 142–143. 5 indexed citations
6.
Mack, Robert A., et al.. (1988). Drug-induced modifications of the immune response. 12. 4,5-Dihydro-4-oxo-2-(substituted amino)-3-furancarboxylic acids and derivatives as novel antiallergic agents. Journal of Medicinal Chemistry. 31(10). 1910–1918. 40 indexed citations
7.
8.
DeCory, Thomas R., G. B. MULLEN, Jeffrey T. Mitchell, et al.. (1988). In Vitro Antifungal Activity of Novel Substituted 3,5‐Diphenyl‐3‐(1H‐imidazol‐1‐ylmethyl)‐2‐methylisoxazolidine Derivativesa. Annals of the New York Academy of Sciences. 544(1). 363–365.
9.
DeCory, Thomas R., G. B. MULLEN, Jeffrey T. Mitchell, et al.. (1988). cis‐3‐(Substituted phenyl)‐3‐(1H‐imidazol‐1‐ylmethyl)‐2‐methyl‐5‐{[(substituted phenyl)thio(or amino)]methyl} isoxazolidines. Annals of the New York Academy of Sciences. 544(1). 366–368. 1 indexed citations
10.
MULLEN, G. B., et al.. (1988). cis‐5‐Alkyl(or alkenyl)‐3‐phenyl‐3‐(1H‐imidazol‐1‐ylmethyl)‐2‐methylisoxazolidine Derivatives. Annals of the New York Academy of Sciences. 544(1). 381–383.
11.
MULLEN, G. B., et al.. (1988). Novel 5‐Phenyl(or phenoxyalkyl)‐3‐(2‐furanyl)‐3‐(1H‐imidazol‐1‐ylmethyl)‐2‐methylisoxazolidines. Annals of the New York Academy of Sciences. 544(1). 384–386.
13.
14.
MULLEN, G. B., et al.. (1988). cis‐5‐Alkoxyalkyl‐3‐phenyl‐3‐(1H‐imidazol‐1‐ ylmethyl)‐2‐methylisoxazolidine Derivativesa. Annals of the New York Academy of Sciences. 544(1). 373–374.
15.
MULLEN, G. B., et al.. (1988). Substituted 5‐Phenoxyalkyl‐3‐phenyl‐3‐(1H‐imidazol‐1‐ylmethyl)‐2‐methylisoxazolidines. Annals of the New York Academy of Sciences. 544(1). 359–362.
16.
MULLEN, G. B., Thomas R. DeCory, Jeffrey T. Mitchell, et al.. (1988). Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)-2-alkylisoxazolidine derivatives. Journal of Medicinal Chemistry. 31(10). 2008–2014. 37 indexed citations
17.
Warren, R P, et al.. (1987). PR 879-317A enhances in vitro immune activity of peripheral blood mononuclear cells from patients with down syndrome. International Journal of Immunopharmacology. 9(8). 919–926. 7 indexed citations
18.
Georgiev, Vassil St., et al.. (1986). New substituted 4‐azatricyclo[4.3.1.13,8]undecane derivatives. Journal of Heterocyclic Chemistry. 23(4). 1023–1025. 3 indexed citations
19.
Kinsolving, C. R., Alice Johnson, & Neil C. Moran. (1975). The uptake of a substituted acridone by rat mast cells in relationship to histamine release: a possible indicator of exocytosis-induced expansion of the plasma membrane.. Journal of Pharmacology and Experimental Therapeutics. 192(3). 654–669. 10 indexed citations
20.
Post, Robert L., et al.. (1960). Membrane Adenosine Triphosphatase as a Participant in the Active Transport of Sodium and Potassium in the Human Erythrocyte. Journal of Biological Chemistry. 235(6). 1796–1802. 906 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026